Detalhe da pesquisa
1.
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis.
Immunology
; 171(2): 198-211, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884280
2.
Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects.
Int J Cancer
; 153(5): 1080-1095, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293858
3.
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
J Transl Med
; 13: 139, 2015 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25933939
4.
Dendritic cells and cytokines in immune rejection of cancer.
Cytokine Growth Factor Rev
; 19(1): 93-107, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18054517
5.
Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
Cytokine Growth Factor Rev
; 58: 66-74, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33071044
6.
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study.
Front Oncol
; 10: 202, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32211314
7.
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.
Int J Cancer
; 124(1): 130-9, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18839429
8.
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications.
Cancers (Basel)
; 11(12)2019 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31817234
9.
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.
Clin Cancer Res
; 25(17): 5231-5241, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171545
10.
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
Cancer Res
; 66(9): 4943-51, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16651452
11.
Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.
Front Immunol
; 9: 552, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29619026
12.
Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.
Biochimie
; 89(6-7): 884-93, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17532550
13.
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells.
Cancer Immunol Res
; 5(7): 604-616, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28615266
14.
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.
Oncotarget
; 7(18): 26361-73, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028869
15.
Role of type I interferon in inducing a protective immune response: perspectives for clinical applications.
Cytokine Growth Factor Rev
; 26(2): 195-201, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25466627
16.
Exploiting dendritic cells in the development of cancer vaccines.
Expert Rev Vaccines
; 12(10): 1195-210, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24090117
17.
Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.
Mol Oncol
; 6(1): 1-14, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22177803
18.
IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use.
Expert Rev Vaccines
; 10(4): 487-98, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21506646
19.
Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Ann N Y Acad Sci
; 1194: 169-78, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20536466
20.
Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial.
Vaccine
; 27(41): 5654-60, 2009 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19635606